The two founding partners of HEN-MAR PRECLINICAL CONSULTANTS have had extensive experiences in preclinical arenas related to the discovery and development of new chemical entities across a spectrum of therapeutic areas, including cardiovascular, urinary, oncology, topicals, and anti-infectives.
As executives and managers within the pharmaceutical industry, Henk and Mark have over 45 years combined commitment to the science, technologies, management and regulatory aspects for the discovery and development phases of potential new drug molecules. They would like to help with the selection and progression of your drugs of the future!
